Modifier genes and Lynch syndrome: some considerations

被引:6
作者
Scott, Rodney J. [1 ]
机构
[1] Univ Newcastle, Discipline Med Genet, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia
关键词
Lynch syndrome; MSH2; MLH1; Modifier genes; Incidence; Survival; COLORECTAL-CANCER; MUTATION; HOMOLOG; PENETRANCE; ASSOCIATION; CARCINOMA; MSH2;
D O I
10.1186/s13053-022-00240-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lynch Syndrome (LS) is a highly variable entity with some patients presenting at very young ages with malignancy whereas others may never develop a malignancy yet carry an unequivocal genetic predisposition to disease. The most frequent LS malignancy remains colorectal cancer, a disease that is thought to involve genetic as well as environmental factors in its aetiology. Environmental insults are undeniably associated with cancer risk, especially those imparted by such activities as smoking and excessive alcohol consumption. Notwithstanding, in an inherited predisposition the expected exposures to an environmental insult are considered to be complex and require knowledge about the respective exposure and how it might interact with a genetic predisposition. Typically, smoking is one of the major confounders when considering environmental factors that can influence disease expression on a background of significant genetic risk. In addition to environmental triggers, the risk of developing a malignancy for people carrying an inherited predisposition to disease can be influenced by additional genetic factors that do not necessarily segregate with a disease predisposition allele. The purpose of this review is to examine the current state of modifier gene detection in people with a genetic predisposition to develop LS and present some data that supports the notion that modifier genes are gene specific thus explaining why some modifier gene studies have failed to identify associations when this is not taken into account.
引用
收藏
页数:4
相关论文
共 24 条
[1]   FAMILIAL ADENOMATOUS POLYPOSIS (FAP) - FREQUENCY, PENETRANCE, AND MUTATION-RATE [J].
BISGAARD, ML ;
FENGER, K ;
BULOW, S ;
NIEBUHR, E ;
MOHR, J .
HUMAN MUTATION, 1994, 3 (02) :121-125
[2]   Evolution of the nomenclature for the hereditary colorectal cancer syndromes [J].
Boland, CR .
FAMILIAL CANCER, 2005, 4 (03) :211-218
[3]   CANCER FAMILY SYNDROME - CASE-REPORT AND LITERATURE-REVIEW [J].
BOLAND, CR .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1978, 23 (05) :S25-S27
[4]   MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
BRONNER, CE ;
BAKER, SM ;
MORRISON, PT ;
WARREN, G ;
SMITH, LG ;
LESCOE, MK ;
KANE, M ;
EARABINO, C ;
LIPFORD, J ;
LINDBLOM, A ;
TANNERGARD, P ;
BOLLAG, RJ ;
GODWIN, AR ;
WARD, DC ;
NORDENSKJOLD, M ;
FISHEL, R ;
KOLODNER, R ;
LISKAY, RM .
NATURE, 1994, 368 (6468) :258-261
[5]   TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY [J].
COUNTER, CM ;
AVILION, AA ;
LEFEUVRE, CE ;
STEWART, NG ;
GREIDER, CW ;
HARLEY, CB ;
BACCHETTI, S .
EMBO JOURNAL, 1992, 11 (05) :1921-1929
[6]   Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report [J].
Dominguez-Valentin, Mev ;
Seppala, Toni T. ;
Sampson, Julian R. ;
Macrae, Finlay ;
Winship, Ingrid ;
Evans, D. Gareth ;
Scott, Rodney J. ;
Burn, John ;
Moeslein, Gabriela ;
Bernstein, Inge ;
Pylvanainen, Kirsi ;
Renkonen-Sinisalo, Laura ;
Lepistoe, Anna ;
Lindblom, Annika ;
Plazzer, John-Paul ;
Tjandra, Douglas ;
Thomas, Huw ;
Green, Kate ;
Lalloo, Fiona ;
Crosbie, Emma J. ;
Hill, James ;
Capella, Gabriel ;
Pineda, Marta ;
Navarro, Matilde ;
Vidal, Joan Brunet ;
Ronlund, Karina ;
Nielsen, Randi Thyregaard ;
Yilmaz, Mette ;
Elvang, Louise Laurberg ;
Katz, Lior ;
Nielsen, Maartje ;
ten Broeke, Sanne W. ;
Nakken, Sigve ;
Hovig, Eivind ;
Sunde, Lone ;
Kloor, Matthias ;
Doeberitz, Magnus von Knebel ;
Ahadova, Aysel ;
Lindor, Noralane ;
Steinke-Lange, Verena ;
Holinski-Feder, Elke ;
Mecklin, Jukka-Pekka ;
Moller, Pal .
HEREDITARY CANCER IN CLINICAL PRACTICE, 2019, 17 (01)
[7]   The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis [J].
Donald, Neil ;
Malik, Salim ;
McGuire, Joshua L. ;
Monahan, Kevin J. .
FAMILIAL CANCER, 2018, 17 (01) :43-52
[8]   THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
FISHEL, R ;
LESCOE, MK ;
RAO, MRS ;
COPELAND, NG ;
JENKINS, NA ;
GARBER, J ;
KANE, M ;
KOLODNER, R .
CELL, 1993, 75 (05) :1027-1038
[9]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[10]   Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer [J].
Heinen, Christopher D. .
DNA REPAIR, 2016, 38 :127-134